|
Match
|
Document |
Document Title |
|
|
US20140377188 |
Oral Composition Indicative Of Proper Tooth Cleaning
The present invention provides an oral care composition, containing at least 0.5% by weight of silica agglomerates, wherein each of the silica agglomerates has: (i) an overall particle size from... |
|
|
US20110264696 |
Pharmaceutical Compositions and Methods for Verifying Dosing Compliance
A pharmaceutical dosage form is provided that has a distinguishing characteristic and an identifier associated with the dosage form. The distinguishing characteristic is assigned from a limited... |
|
|
US20150105258 |
Methods For Controlling Pests
Ready-to-use foamable pesticide compositions that contain a particulate pesticide suspended therein and applicators for dispensing such compositions. Methods for treating pests such as arthropods... |
|
|
US20130012386 |
Methods For Controlling Pests
Ready-to-use foamable pesticide compositions that contain a particulate pesticide suspended therein and applicators for dispensing such compositions. Methods for treating pests such as arthropods... |
|
|
US20130287705 |
METHOD OF TREATING MUCOSAL INFLAMMATION
A method of treating mucosal inflammation associated with a pathological condition in a mammal is provided. The method comprises the step of inhibiting 5-HT signaling at a target site in order to... |
|
|
US20110052505 |
Post-biopsy cavity treatment implants and methods
A post-biopsy cavity treatment implant includes a radiopaque element, a core portion and a shell portion. The core portion is coupled to the radiopaque element, and includes a first porous matrix... |
|
|
US20140170079 |
ABUSE-PROOFED DOSAGE FORM
The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of... |
|
|
US20130171075 |
ABUSE-PROOFED DOSAGE FORM
The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of... |
|
|
US20140086847 |
DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE
The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking... |
|
|
US20130101524 |
SEMULOPARIN FOR THE EXTENDED PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT HAVING UNDERGONE HIP FRACTURE SURGERY
The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof for the extended prevention of a mortality and/or morbidity event, more specifically venous... |
|
|
US20150190315 |
CHEMICALLY TREATED CLOTH AND CLOTHING AND METHOD OF MANUFACTURE THEREOF
A piece of cloth or clothing treated with a chemical application or combination of chemicals or ingredients which help in cleaning the skin and reducing acne. Other benefits may also be provided... |
|
|
US20120294811 |
PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME
A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the chorion tissue from the amniotic... |
|
|
US20120294810 |
PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME
A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the chorion tissue from the amniotic... |
|
|
US20060062733 |
Medicament/dosimeter combination packaging
In a system for individual dosing of a medicament, in accordance with the individual pathological properties (“fingerprint”) of a patient—corresponding physiologically or genetically to the... |
|
|
US20080145316 |
Skin coating with microbial indicator
Skin sealants are usually applied over skin preps to seal the skin and hold any remaining bacteria in place prior to surgical incisions. This sealant is generally left on the skin after surgery. A... |
|
|
US20150237849 |
Dosage Regime for Animal Treatment
The invention relates to a dosage regime for treating an animal over a pest season, the dosage regime comprising a first dosage projectile having a unique identifier and containing a first... |
|
|
US20110300079 |
COMPOSITIONS FOR USE WITH A SYSTEM FOR IMPROVED COOLING OF SUBCUTANEOUS LIPID-RICH TISSUE
A composition or cryoprotectant for use with a system for improved cooling of subcutaneous lipid-rich tissue of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel,... |
|
|
US20130108555 |
Compositions for visualization of cleaning efficacy and product coverage
The invention relates to cleaning and food processing aide applications whereby unique compositions of GRAS or food additives were developed to assess the effectiveness of cleaning procedures at... |
|
|
US20140010764 |
GLYCATED MILK AND USES THEREOF
Milk-based products and drinks are provided including specified forms of identified proteins or fragments thereof, as are methods for the use of such milk-based products and drinks in the... |
|
|
US20100297027 |
Overt authentication features for compositions and objects and methods of fabrication and verification thereof
Overt anti-counterfeiting features on objects and compositions, especially pharmaceutical compositions. In a preferred embodiment, a counterfeiting-proof overt feature that presents a visually... |
|
|
US20140255318 |
NITRIC OXIDE RELEASING BATH COMPOSITIONS AND METHODS OF USING THE SAME
The present invention relates to bath compositions that may release nitric oxide when combined with an aqueous solution, thereby producing a nitric oxide releasing soak and/or bath. The present... |
|
|
US20150056147 |
ABUSE-PROOFED DOSAGE FORM
A solid administration form, protected from parenteral abuse and containing at least one viscosity-increasing agent in addition to one or more active substances that have parenteral abuse... |
|
|
US20130023736 |
SYSTEMS FOR DRUG DELIVERY AND MONITORING
Films that comprise an active agent for delivery to a tissue. The films may include carboxyls that form a chemical association with the active agent and/or hydrophilic domains or particles that... |
|
|
US20070092451 |
Time indicating containers for dental compositions
A system for storing a dental composition having a given shelf-life. The storage system includes a container (e.g., a syringe) and activatable time sensitive marking means disposed on or within... |
|
|
US20140314680 |
Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
A dual release oral dosage system/dosage form comprising an immediate release component/composition and a delayed release component/composition is described. Each of the immediate release... |
|
|
US20110165091 |
METHOD AND COMPOSITION FOR DELIVERY OF MEDICANTS TO ANIMALS
According to the present invention, a vaccine or pharmaceutical-containing composition is applied to the muzzle area of the animal, which will then naturally use its tongue to clean itself. This... |
|
|
US20120301405 |
Simple Mechanical Procedure and Product for Deterring Substance Abuse.
A drug-formulating method, a drug commercial-distribution method, and a drug formulation improve safety of a drug that is at risk for abuse—such as methylphenidate, or amphetamine, or an... |
|
|
US20070048365 |
Edible coded microsubstrate for pharmaceuticals
A system for verifying product authenticity. A verification system may include: coded microstructures contained within a product. In particular implementations, such as pharmaceuticals, the... |
|
|
US20130272969 |
Injectable Cross-Linked Polymeric Preparations and Uses Thereof
A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room... |
|
|
US20130071336 |
Injectable Cross-Linked Polymeric Preparations and Uses Thereof
A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room... |
|
|
US20070065365 |
Abuse-resistant transdermal system
An abuse-resistant transdermal system which contains, in addition to one or more active ingredients with potential for abuse, at least one gel-forming agent in quantities such that it forms a gel... |
|
|
US20060210480 |
Treatment of reduction of dysphagia
The present invention provides methods of treating or reducing dysphagia in patients. In one aspect of the invention, such method comprises administering to a patient in need of such treatment or... |
|
|
US20150010478 |
ANTIMICROBIAL DISPOSABLE ABSORBENT ARTICLES
Disposable absorbent articles comprising an absorbent material and an antimicrobial composition are disclosed. The antimicrobial composition includes a carrier comprising fatty alcohol and a... |
|
|
US20130272968 |
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
The present invention is directed to the neutralizing prolactin receptor antibody 006-H08, as well as maturated forms thereof, and antigen-binding fragments, pharmaceutical compositions containing... |
|
|
US20080085245 |
TOPICAL ANESTHETIC COMPOSITION
A method for providing anesthesia to a subject having a wound, such as a laceration, a surgical incision, an ulcer, an abrasion or a burn, said method comprising the step of applying topically to... |
|
|
US20100068153 |
Ex vivo activatable final dosage form
Provided embodiments include a final dosage form, an article of manufacture, and method. A final dosage form for administering a medicament to an animal is provided. The final dosage form includes... |
|
|
US20060165602 |
Method for deterring abuse of opioids by combination with non-release formulation of emetic
The present invention pertains to a pharmaceutical dosage form comprising an opioid and a sequestered emetic. When abuse is attempted by crushing, chewing, or otherwise compromising the... |
|
|
US20060182688 |
Metronidazole-based tinted topical pharmaceutical compositions
Topically applicable pharmaceutical compositions suited for the treatment of dermatological complaints, conditions or afflictions, notably rosacea, contain a thus effective amount of metronidazole... |
|
|
US20130266520 |
ORAL FILM DOSAGE FORM HAVING PHYSICAL-CHEMICAL IDENTIFIER THEREON
The present invention relates to rapidly dissolving edible film dosage form incorporating a physical-chemical identifier and/or indicia. The physical-chemical identifier and/or indicia may... |
|
|
US20110177010 |
Vitamin preparation
Two-phase preparation for temporally gradual administration comprising a) a phase (A) comprising water soluble vitamins and/or the corresponding provitamins, wherein phase (A) does not contain... |
|
|
US20080311049 |
ABUSE-PROOF DOSAGE FORM
The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of... |
|
|
US20070183980 |
DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE
The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking... |
|
|
US20050031546 |
Abuse-proffed dosage form
The present invention relates to an abuse-proofed, thermoformed dosage form containing, in addition to one or more active ingredients with abuse potential optionally together with physiologically... |
|
|
US20130022552 |
BLOOD CLOTTING COMPOSITION AND METHOD OF USE
The composition is a blood clotting composition including at least one hemostatic agent and an indicator agent that adheres to the skin on or around the wound, the indicator agent being... |
|
|
US20060193782 |
Abuse-proofed dosage form
The invention relates to a form of administration which is secured against misuse and which is thermoformed without extrusion, including at least one synthetic or natural polymer having a... |
|
|
US20080247959 |
FORM OF ADMINISTRATION SECURED AGAINST MISUSE
The invention relates to a form of administration which is thermoformed without extrusion, comprising at least one synthetic or natural polymer having a resistance to breaking of at least 500 N in... |
|
|
US20130287704 |
ARTICLE AND METHODS FOR ORAL SELF-ADMINISTRATION OF NICOTINE
The invention discloses an article for swaddling in the mouth to deliver pharmacologically active substances, particularly nicotine, in combination with dyes or flavorings, across the buccal... |
|
|
US20050214223 |
Abuse-safeguarded dosage form
A pharmaceutical dosage form that is safeguarded against abuse containing at least one active substance that is susceptible to abuse and at least two of the following constituents (a) through (d):... |
|
|
US20070224128 |
Drug adherence monitoring system
The present invention provides novel methods for monitoring subject adherence in taking prescribed drugs by detecting markers in exhaled breath after a subject takes the prescribed drug. In... |
|
|
US20070065364 |
Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same
The present invention relates to co-extruded pharmaceutical compositions and dosage forms comprising an adverse agent, such as an opioid antagonist, which can be sequestered. The pharmaceutical... |